A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
Information source: Alcon Research
ClinicalTrials.gov processed this data on August 20, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Open-angle Glaucoma; Ocular Hypertension
Intervention: Brinzolamide/Timolol (Drug)
Phase: Phase 2
Status: Completed
Sponsored by: Alcon Research Official(s) and/or principal investigator(s): Julia White, Study Director, Affiliation: Study Director
Summary
The purpose of this study is to assess the comfort of a glaucoma therapy in patients with
open-angle glaucoma or ocular hypertension
Clinical Details
Official title: A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment
Primary outcome: Ocular discomfort
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Adults of either sex and any race diagnosed with open-angle glaucoma (with or without
pseudoexfoliation or pigment dispersion component)
Exclusion Criteria:
- Under 18
Locations and Contacts
Fort Worth and Other Sites, Fort Worth, Texas 76134, United States
Additional Information
Starting date: May 2006
Last updated: June 3, 2012
|